According to Cognitive Market Research, the global ischemic heart disease market size was USD 6514.5 million in 2024. It will expand at a compound annual growth rate (CAGR) of 4.50% from 2024 to 2031.
North America held the major market share for more than 40% of the global revenue with a market size of USD 2605.80 million in 2024 and will grow at a compound annual growth rate (CAGR) of 2.7% from 2024 to 2031.
Europe accounted for a market share of over 30% of the global revenue with a market size of USD 1954.35 million.
Asia Pacific held a market share of around 23% of the global revenue with a market size of USD 1498.34 million in 2024 and will grow at a compound annual growth rate (CAGR) of 6.5% from 2024 to 2031.
Latin America had a market share of more than 5% of the global revenue with a market size of USD 325.73 million in 2024 and will grow at a compound annual growth rate (CAGR) of 3.9% from 2024 to 2031.
Middle East and Africa had a market share of around 2% of the global revenue and was estimated at a market size of USD 130.29 million in 2024 and will grow at a compound annual growth rate (CAGR) of 4.2% from 2024 to 2031.
The unstable angina category is the fastest growing segment of the ischemic heart disease industry
